凝血酶原时间与血小板检验方式对肝硬化疾病患者诊断的效果分析

Analysis of effects by prothrombin time and blood platelet test in diagnosis of liver cirrhosis diseases patients

目的分析凝血酶原时间与血小板检验方式在肝硬化疾病诊断中的应用效果。方法 67例肝硬化患者作为甲组,67例体检正常健康者作为乙组,均进行凝血酶原时间与血小板检验,观察两组检测差异。结果甲组血小板计数(67.84±15.01)×109/L与大血小板压积(0.17±0.04)%低于乙组,血小板分布宽度(20.78±2.15)fl与凝血酶原时间(21.38±2.45)s高于乙组(P<0.05)。结论凝血酶原时间与血小板检验的特异性表现可作为诊断肝硬化患者的重要指标,为早期治疗提供可靠依据,值得临床借鉴采用。

Objective To analyze application effects by prothrombin time and blood platelet test in diagnosis of liver cirrhosis diseases patients. Methods There were 67 patients with liver cirrhosis as group A and 67 healthy people as group B. They all received prothrombin time and blood platelet test, and their differences in test were observed. Results Group A had lower blood platelet count as（67.84±15.01） ×109/L and large platelet hematocrit as（0.17±0.04）% than group B. While group A had all higher blood platelet distribution width as（20.78±2.15） fl and prothrombin time as（21.38±2.45） s than group B（P〈0.05）. Conclusion Specificity manifestation of prothrombin time and blood platelet test can be taken as important index in diagnosis of liver cirrhosis patients. This method can provide creditable evidence for early treatment, and it is worth clinical reference and application.